Cargando…
The Emerging Role of Venetoclax-Based Treatments in Acute Lymphoblastic Leukemia
Venetoclax, a B-cell lymphoma (BCL-2) inhibitor, in combination with hypomethylating agents has become the new standard of care in elderly and unfit patients with acute myeloid leukemia, with significantly improved overall survival and quality of life. Studies of venetoclax combined with high-dose c...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504828/ https://www.ncbi.nlm.nih.gov/pubmed/36142863 http://dx.doi.org/10.3390/ijms231810957 |